Product Information
FLUTICASONE-SALMETEROL 230-21 is a generic product labeled by Prasco Laboratories, priced at $26.7460 per GM under NDC 66993008896. Its NADAC has been published 163 times since Aug 23, 2023.
FDA first approved this application on Jun 8, 2006.
Strength
230; 21 ug/1; ug/1
Manufacturer
Prasco LaboratoriesNDC
66993008896
Classification
Generic
Dosage Form
AEROSOL, METERED
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021254FDA Approved
6/8/2006
On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE-SALMETEROL 230-21 has been published 163 times since Aug 23, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.7460 per GM |
|---|---|
| All-time high | $28.0740 (Apr 10, 2024) |
| All-time low | $25.1775 (Jul 17, 2024) |
| 52-week high | $27.4432 |
| 52-week low | $26.7142 |
| Median price | $26.9301 |
| Average price | $26.7810 |
| Largest weekly change | -9.9% (Apr 17, 2024) |
| Weeks tracked | 163 |
| Tracking since | Aug 23, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluticasone propionate and salmeterol xinafoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUTICASONE-SALMETEROL 230-21?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE-SALMETEROL 230-21, manufactured by Prasco Laboratories, is $26.7460 per GM (NDC 66993008896), effective Sep 30, 2026.
How has the price of FLUTICASONE-SALMETEROL 230-21 changed over time?
Over the history we have for it, the NADAC for FLUTICASONE-SALMETEROL 230-21 has held within roughly two percent of its current level. It has been tracked across 163 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for FLUTICASONE-SALMETEROL 230-21?
Since Aug 23, 2023, the NADAC for FLUTICASONE-SALMETEROL 230-21 has ranged from a low of $25.1775 (Jul 17, 2024) to a high of $28.0740 (Apr 10, 2024), with a median of $26.9301 per GM.
Are there cheaper alternatives to FLUTICASONE-SALMETEROL 230-21?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FLUTICASONE-SALMETEROL 230-21 in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUTICASONE-SALMETEROL 230-21?
FLUTICASONE-SALMETEROL 230-21 (NDC 66993008896) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.